Early adverse events and patient-reported outcomes after salvage radiotherapy following prostatectomy according to fractionation schedule: Interim analysis of the phase III URONCOR 06-24 trial.

Couñago F, González C, Gómez-Iturriaga A, Álvarez A, Santos M, Boladeras A, García N, Fernández S, Guardado S, Ocanto A, Gonsalves D, Glaría L, Castaño A, Martín P, Montezuma L, Mera A, Mases J, Meca G, Duque-Santana V, Olivera J, Pérez S, Henriquez I, Malavé B, Rodríguez A, García R, Büchser D, Garre J, Altabas M, Valero J, García-Gómez R, Berenguer M, Calvo Á, Ordoñez R, Willisch P, Candal A, Aymar N, Mayrata E, López-Campos F

Open source

DOI
10.1016/j.ctro.2026.101276
Published
2026 Nov
Container
Clinical and translational radiation oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ctro.2026.101276,
  title = {Early adverse events and patient-reported outcomes after salvage radiotherapy following prostatectomy according to fractionation schedule: Interim analysis of the phase III URONCOR 06-24 trial.},
  author = {Couñago F and González C and Gómez-Iturriaga A and Álvarez A and Santos M and Boladeras A and García N and Fernández S and Guardado S and Ocanto A and Gonsalves D and Glaría L and Castaño A and Martín P and Montezuma L and Mera A and Mases J and Meca G and Duque-Santana V and Olivera J and Pérez S and Henriquez I and Malavé B and Rodríguez A and García R and Büchser D and Garre J and Altabas M and Valero J and García-Gómez R and Berenguer M and Calvo Á and Ordoñez R and Willisch P and Candal A and Aymar N and Mayrata E and López-Campos F},
  year = {2026},
  journal = {Clinical and translational radiation oncology},
  doi = {10.1016/j.ctro.2026.101276},
  url = {https://doi.org/10.1016/j.ctro.2026.101276}
}

RIS

TY  - JOUR
TI  - Early adverse events and patient-reported outcomes after salvage radiotherapy following prostatectomy according to fractionation schedule: Interim analysis of the phase III URONCOR 06-24 trial.
AU  - Couñago F
AU  - González C
AU  - Gómez-Iturriaga A
AU  - Álvarez A
AU  - Santos M
AU  - Boladeras A
AU  - García N
AU  - Fernández S
AU  - Guardado S
AU  - Ocanto A
AU  - Gonsalves D
AU  - Glaría L
AU  - Castaño A
AU  - Martín P
AU  - Montezuma L
AU  - Mera A
AU  - Mases J
AU  - Meca G
AU  - Duque-Santana V
AU  - Olivera J
AU  - Pérez S
AU  - Henriquez I
AU  - Malavé B
AU  - Rodríguez A
AU  - García R
AU  - Büchser D
AU  - Garre J
AU  - Altabas M
AU  - Valero J
AU  - García-Gómez R
AU  - Berenguer M
AU  - Calvo Á
AU  - Ordoñez R
AU  - Willisch P
AU  - Candal A
AU  - Aymar N
AU  - Mayrata E
AU  - López-Campos F
PY  - 2026
JO  - Clinical and translational radiation oncology
DO  - 10.1016/j.ctro.2026.101276
UR  - https://doi.org/10.1016/j.ctro.2026.101276
ER  -

APA

F, C., C, G., A, G., A, Á., M, S., A, B., N, G., S, F., S, G., A, O., D, G., L, G., A, C., P, M., L, M., A, M., J, M., G, M., V, D., J, O., S, P., I, H., B, M., A, R., R, G., D, B., J, G., M, A., J, V., R, G., M, B., Á, C., R, O., P, W., A, C., N, A., E, M., & F, L. (2026). Early adverse events and patient-reported outcomes after salvage radiotherapy following prostatectomy according to fractionation schedule: Interim analysis of the phase III URONCOR 06-24 trial.. Clinical and translational radiation oncology. https://doi.org/10.1016/j.ctro.2026.101276

Source records